BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 33725814)

  • 1. Low-grade ductal carcinoma in situ (DCIS) arising in a fibroadenoma of the breast during 5 years follow-up: A case report.
    Shojaku H; Hori R; Yoshida T; Matsui K; Shimada K; Takayanagi N; Noguchi K
    Medicine (Baltimore); 2021 Mar; 100(10):e24023. PubMed ID: 33725814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative diagnosis of ductal carcinoma in situ arising within a mammary fibroadenoma: a case report.
    Ooe A; Takahara S; Sumiyoshi K; Yamamoto H; Shiba E; Kawai J
    Jpn J Clin Oncol; 2011 Jul; 41(7):918-23. PubMed ID: 21693482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Uncommon Pairing of common Tumors: Case Report of Ductal Carcinoma
    Marumoto A; Steinemann S; Furumoto N; Woodruff S
    Hawaii J Med Public Health; 2019 Feb; 78(2):39-43. PubMed ID: 30766763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes.
    Virnig BA; Tuttle TM; Shamliyan T; Kane RL
    J Natl Cancer Inst; 2010 Feb; 102(3):170-8. PubMed ID: 20071685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Availability of immunocytochemistry using cocktail antibody targeting p63/cytokeratin14 for the differential diagnosis of fibroadenoma and ductal carcinoma in situ in fine needle aspiration cytology of the breast.
    Maeda I; Oana Y; Tsugawa K; Takagi M
    Cytopathology; 2017 Oct; 28(5):378-384. PubMed ID: 28685877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis, characteristics, and treatment of breast carcinomas within benign fibroepithelial tumors.
    Saimura M; Koga K; Anan K; Mitsuyama S; Tamiya S
    Breast Cancer; 2018 Jul; 25(4):470-478. PubMed ID: 29460095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidental DCIS within a fibroadenoma.
    Chen A; Kanakaratne S; Britten-Jones P; Bingham J
    BMJ Case Rep; 2023 Sep; 16(9):. PubMed ID: 37751969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic MR findings of ductal carcinoma in situ within a fibroadenoma.
    Kato F; Omatsu T; Matsumura W; Takahashi M; Hosoda M; Takahashi H; Kubota K; Oyama-Manabe N; Terae S; Shirato H
    Magn Reson Med Sci; 2011; 10(2):129-32. PubMed ID: 21720115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ductal and lobular carcinoma in situ arising within an enlarging biopsy proven fibroadenoma.
    Feliciano YZ; Freire R; Net J; Yepes M
    BMJ Case Rep; 2021 Jan; 14(1):. PubMed ID: 33468635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ductal Carcinoma in Situ: A French National Survey. Analysis of 2125 Patients.
    Cutuli B; Lemanski C; De Lafontan B; Chauvet MP; De Lara CT; Mege A; Fric D; Richard-Molard M; Mazouni C; Cuvier C; Carre A; Kirova Y
    Clin Breast Cancer; 2020 Apr; 20(2):e164-e172. PubMed ID: 31780381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. When pathological and radiological correlation is achieved, excision of fibroadenoma with lobular neoplasia on core biopsy is not warranted.
    Fives C; O'Neill CJ; Murphy R; Corrigan MA; O'Sullivan MJ; Feeley L; Bennett MW; O'Connell F; Browne TJ
    Breast; 2016 Dec; 30():125-129. PubMed ID: 27718416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal management of ductal carcinoma in situ of the breast.
    Sakorafas GH; Farley DR
    Surg Oncol; 2003 Dec; 12(4):221-40. PubMed ID: 14998563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secondary breast carcinoma after completely remitted chronic myeloid leukemia following targeted tyrosine kinase inhibitor therapy.
    Pan L; Duan J; Qiao W; Bi L; Wu D; Fan Z; Yang M
    Breast Cancer; 2017 Nov; 24(6):790-793. PubMed ID: 28585003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypofractionated radiation therapy for durable palliative treatment of bleeding, fungating breast cancers.
    Grewal AS; Freedman GM; Jones JA; Taunk NK
    Pract Radiat Oncol; 2019 Mar; 9(2):73-76. PubMed ID: 30665864
    [No Abstract]   [Full Text] [Related]  

  • 15. Diagnosis and management of ductal carcinoma in situ (DCIS).
    Virnig BA; Shamliyan T; Tuttle TM; Kane RL; Wilt TJ
    Evid Rep Technol Assess (Full Rep); 2009 Sep; (185):1-549. PubMed ID: 20629475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ductal carcinoma in situ, complexities and challenges.
    Leonard GD; Swain SM
    J Natl Cancer Inst; 2004 Jun; 96(12):906-20. PubMed ID: 15199110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast carcinoma in situ in 167 women--incidence, mode of presentation, therapy and follow-up.
    Ringberg A; Andersson I; Aspegren K; Linell F
    Eur J Surg Oncol; 1991 Oct; 17(5):466-76. PubMed ID: 1657650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contralateral breast cancer adjacent to a fibroadenoma: report of a case.
    Iwamoto M; Takei H; Iida S; Yamashita K; Yanagihara K; Kurita T; Tsuchiya S; Kanazawa Y; Uchida E
    J Nippon Med Sch; 2014; 81(3):168-72. PubMed ID: 24998964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The significance of extracellular mucin in breast fine needle aspiration specimens.
    Shield PW; Ribu DL; Cominos D
    Cytopathology; 2016 Jun; 27(3):185-92. PubMed ID: 26104545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ductal carcinoma in situ of the breast: our experience.
    Ruggiero R; Procaccini E; Sanguinetti A; Cremone C; Gili S; Docimo G; Docimo L; Sparavigna L; Gubitosi A; Parmeggiani D; Avenia N
    G Chir; 2009 Mar; 30(3):121-4. PubMed ID: 19351465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.